NCT02995733 Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief Status COMPLETED Phase PHASE4
NCT02994238 iTRACC (Improving Technology-Assisted Recording of Asthma Control in Children) Status COMPLETED Phase NA
NCT02991859 Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects Status COMPLETED Phase PHASE2
NCT02991781 Combined Bio- and Neuro- Feedback vs. Varenicline Use for Smoking Cessation Status COMPLETED Phase NA
NCT02991391 Expansion of the COPD At-risk Module in 4 States BRFSS Telephone Health Surveys Status COMPLETED Phase N/A
NCT02990247 Home Telemonitoring of Resting Spontaneous Breathing in Severe Asthma: a Pilot Study Status COMPLETED Phase NA
NCT02983994 Errors in the Use of Turbuhaler and Spiromax Devices Patients With Asthma Status COMPLETED Phase N/A
NCT02980133 Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler Status COMPLETED Phase PHASE3
NCT02975843 Lung Deposition of Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide Administered Via pMDI in Healthy, Asthmatic and COPD Patients Status COMPLETED Phase PHASE1
NCT02975258 Adiposity and Airway Inflammation in HIV-Associated Airway Disease Status COMPLETED Phase N/A
NCT02969408 A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma Status COMPLETED Phase PHASE3
NCT02968914 Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02967159 A Study to Evaluate the Disposition of Drug in Body and Safety After Administration of Single Inhaled Doses of Drugs Abediterol and AZD7594 Administered Alone, in Fixed Dose Combination and in Free Combination Using the Dry Powder Inhaler in Healthy Male Participants Status COMPLETED Phase PHASE1
NCT02965482 Investigation of Novel Procedure for Methacholine Challenge Testing Status COMPLETED Phase NA
NCT02958982 Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 of Rhizen Pharmaceuticals Status TERMINATED Phase PHASE1/PHASE2
NCT02953041 Effect of a LAMA and a uLABA on the Methacholine Dose-response Curve Status COMPLETED Phase PHASE4
NCT02950116 Lung Clearance Index (LCI) in Pediatric Patients With Obstructive Lung Disease Status TERMINATED Phase NA